Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · IEX Real-Time Price · USD

0.628

-0.030 (-4.49%)

At close: Apr 25, 2024, 3:58 PM

0.620

-0.007 (-1.18%)

After-hours: Apr 25, 2024, 5:31 PM EDT

Monopar Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	7.27	8.19	20.3	16.74	13.21	6.89	9.78	2.87
Short-Term Investments	0	4.93	0	0	0	0	0	0
Cash & Cash Equivalents	7.27	13.12	20.3	16.74	13.21	6.89	9.78	2.87
Cash Growth	-44.62%	-35.38%	21.31%	26.66%	91.71%	-29.54%	240.48%	-
Other Current Assets	0.07	0.05	0.22	0.06	0.02	0.36	-0.65	-0.78
Total Current Assets	7.33	13.17	20.52	16.8	13.23	7.25	9.13	2.1
Property, Plant & Equipment	0.01	0.06	0	0	0	0	0	0
Other Long-Term Assets	0	0	0	0.07	0.12	0.07	0.8	0.8
Total Long-Term Assets	0.01	0.06	0	0.07	0.12	0.07	0.8	0.8
Total Assets	7.35	13.23	20.52	16.87	13.35	7.32	9.93	2.9
Accounts Payable	1.76	3.13	1.58	1.18	0.72	0.4	0.31	0.06
Total Current Liabilities	1.76	3.13	1.58	1.18	0.72	0.4	0.31	0.06
Long-Term Debt	0	0.01	0	0	0	0	0	0
Total Long-Term Liabilities	0	0.01	0	0	0	0	0	0
Total Liabilities	1.76	3.14	1.58	1.18	0.72	0.4	0.31	0.06
Total Debt	0	0.01	0	0	0	0	0	0
Retained Earnings	-60.21	-51.8	-41.29	-32.19	-25.88	-21.66	-18.43	-1.87
Comprehensive Income	-0.01	0.01	-0	-0.01	-0.01	-0	0	0
Shareholders' Equity	5.59	10.09	18.94	15.69	12.63	6.92	9.62	2.83
Net Cash / Debt	7.27	13.11	20.3	16.74	13.21	6.89	9.78	2.87
Net Cash / Debt Growth	-44.58%	-35.42%	21.31%	26.66%	91.71%	-29.54%	240.48%	-
Net Cash Per Share	0.53	1.03	1.63	1.53	1.42	0.74	1.11	-
Working Capital	5.58	10.04	18.94	15.62	12.51	6.85	8.82	2.03
Book Value Per Share	0.40	0.79	1.52	1.43	1.35	0.74	1.09	0.30

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).